[CrossRef] Metabolites 2023,13, 465 16 of 18 51
The rising prevalence of type 2 diabetes mellitus and obesity, rising adoption of technology, and increasing investments drive the market
To explore the differences between injections and oral Lipo, please CLICK HERE for more detailed information on each route of administration
Moreover, the growing physician preference for treatments that offer both metabolic and cardiovascular benefits, growing emphasis on preventive cardiology, and expanding guidelines supporting the use of these therapies in high-risk cardiovascular patients are all factors driving segment growth
Actin collapse in disulfidptosis activates RIPK1-dependent necroptosis, while redox imbalance triggers mitochondrial apoptosis [124]